Share on StockTwits

Shares of Vectura Group PLC (LON:VEC) have earned a consensus recommendation of “Buy” from the twelve ratings firms that are currently covering the stock, ARN reports. Three analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is GBX 178 ($3.00).

Several analysts have recently commented on the stock. Analysts at N+1 Singer reiterated a “hold” rating on shares of Vectura Group PLC in a research note on Thursday, July 24th. They now have a GBX 135 ($2.27) price target on the stock. Separately, analysts at FinnCap reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Thursday, July 17th. They now have a GBX 202 ($3.40) price target on the stock. Finally, analysts at Oriel Securities Ltd reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Thursday, July 17th. They now have a GBX 207 ($3.48) price target on the stock.

Vectura Group PLC (LON:VEC) opened at 135.00 on Wednesday. Vectura Group PLC has a 1-year low of GBX 92.75 and a 1-year high of GBX 171.50. The stock’s 50-day moving average is GBX 138.1 and its 200-day moving average is GBX 143.. The company’s market cap is £539.9 million.

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.